ReviewFrontiers in medicine2021

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?

Dan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.